Jason Meyenburg - Chief Commercial Officer, Sucampo Pharmaceuticals, Inc

As of February 13, 2018


Jason Meyenburg Net Worth

  • Net worth is estimated to be at least $591.94K
  • Owns at least 30,228 units of Sucampo Pharmaceuticals, Inc stock
  • Sold an estimated value of $544.1K in the last year at Sucampo Pharmaceuticals, Inc

Jason Meyenburg Trading

  • Largest purchase of shares was 4,000 units , worth over $48.5K on September 8, 2017
  • In total has made about 2 transactions over a year
  • Usually trades in February and September, with the busiest year in 2018 and 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jason Meyenburg Mailing Address

  • Mailing address is C/o Sucampo Pharmaceuticals 805 King Farm Boulevard, Suite 550 Rockville MD 20850 MD

Sucampo Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 50,000 units sold on December 11, 2017 by Peter Kiener worth over $825K
  • In the last 2 years, insiders at Sucampo Pharmaceuticals, Inc sold an estimated value of $294.42M and bought an estimated value of $5.61M
  • The most active traders are Matthew Maxwell Donley, EVP,  Peter Kiener, Chief Science Officer,  and Peter Greenleaf, Chief Executive Officer
  • Insider trading is most common in June and March, with the busiest year in 2017 and 2016

Sucampo Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1